4//SEC Filing
Ingalls Kerry D. 4
Accession 0001209191-21-008135
CIK 0001661460other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:53 PM ET
Size
5.5 KB
Accession
0001209191-21-008135
Insider Transaction Report
Form 4
Ingalls Kerry D.
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-02-04+137,000→ 137,000 totalExercise: $9.15Exp: 2031-02-03→ Common Stock (137,000 underlying)
Footnotes (1)
- [F1]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001816804
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:53 PM ET
- Size
- 5.5 KB